Annual SGA
$11.61 M
+$3.08 M+36.10%
December 31, 2023
Summary
- As of February 8, 2025, ONCY annual SGA is $11.61 million, with the most recent change of +$3.08 million (+36.10%) on December 31, 2023.
- During the last 3 years, ONCY annual SGA has risen by +$2.27 million (+24.33%).
- ONCY annual SGA is now at all-time high.
Performance
ONCY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.28 M
-$181.10 K-7.37%
September 30, 2024
Summary
- As of February 8, 2025, ONCY quarterly SGA is $2.28 million, with the most recent change of -$181.10 thousand (-7.37%) on September 30, 2024.
- Over the past year, ONCY quarterly SGA has dropped by -$1.63 million (-41.69%).
- ONCY quarterly SGA is now -41.69% below its all-time high of $3.90 million, reached on September 30, 2023.
Performance
ONCY Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.35 B
-$22.44 M-1.68%
September 30, 2024
Summary
- As of February 8, 2025, ONCY TTM SGA is -$1.35 billion, with the most recent change of -$22.44 million (-1.68%) on September 30, 2024.
- Over the past year, ONCY TTM SGA has dropped by -$1.37 billion (-11922.31%).
- ONCY TTM SGA is now -233034.69% below its all-time high of -$581.20 thousand.
Performance
ONCY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ONCY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | -41.7% | -10000.0% |
| 3 y3 years | +24.3% | -13.4% | -10000.0% |
| 5 y5 years | - | -13.4% | -10000.0% |
ONCY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.1% | -41.7% | +30.0% | -11.6% | at low |
| 5 y | 5-year | at high | +36.1% | -41.7% | +30.0% | -36.7% | at low |
| alltime | all time | at high | >+9999.0% | -41.7% | +185.2% | <-9999.0% | at low |
Oncolytics Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.28 M(-7.4%) | $9.73 M(-14.3%) |
| Jun 2024 | - | $2.46 M(+11.1%) | $11.35 M(-1.0%) |
| Mar 2024 | - | $2.21 M(-20.5%) | $11.47 M(-1.3%) |
| Dec 2023 | $11.61 M(+36.1%) | $2.78 M(-28.7%) | $11.62 M(+1.4%) |
| Sep 2023 | - | $3.90 M(+51.8%) | $11.46 M(+23.1%) |
| Jun 2023 | - | $2.57 M(+8.9%) | $9.31 M(+4.8%) |
| Mar 2023 | - | $2.36 M(-10.1%) | $8.88 M(+3.6%) |
| Dec 2022 | $8.53 M(-16.8%) | $2.63 M(+50.1%) | $8.58 M(-0.1%) |
| Sep 2022 | - | $1.75 M(-18.5%) | $8.59 M(-5.9%) |
| Jun 2022 | - | $2.15 M(+4.6%) | $9.12 M(+30.8%) |
| Mar 2022 | - | $2.05 M(-22.1%) | $6.97 M(+41.7%) |
| Dec 2021 | $10.26 M(+9.8%) | $2.64 M(+15.5%) | $4.92 M(+115.5%) |
| Sep 2021 | - | $2.28 M(+124.0%) | $2.28 M(-29.4%) |
| Dec 2020 | $9.34 M(+2400.6%) | - | - |
| Sep 2011 | - | $1.02 M(-5.0%) | $3.24 M(-6.9%) |
| Jun 2011 | - | $1.07 M(-6.1%) | $3.47 M(-0.8%) |
| Mar 2011 | - | $1.14 M(-9.2%) | $3.50 M(+217.6%) |
| Sep 2010 | - | $1.26 M(+14.2%) | $1.10 M(+110.9%) |
| Jun 2010 | - | $1.10 M(+18.9%) | $522.90 K(+92.7%) |
| Mar 2010 | - | $926.70 K(-142.4%) | $271.40 K(+83.3%) |
| Dec 2009 | $373.50 K(+519.4%) | -$2.18 M(-421.9%) | $148.10 K(-143.7%) |
| Sep 2009 | - | $678.20 K(-20.2%) | -$338.70 K(+119.1%) |
| Jun 2009 | - | $849.90 K(+5.8%) | -$154.60 K(-148.3%) |
| Mar 2009 | - | $803.40 K(-130.1%) | $319.80 K(-47.9%) |
| Dec 2008 | $60.30 K(-98.6%) | -$2.67 M(-409.7%) | $614.40 K(-87.7%) |
| Sep 2008 | - | $862.30 K(-34.9%) | $4.99 M(+1.0%) |
| Jun 2008 | - | $1.32 M(+20.6%) | $4.94 M(+7.5%) |
| Mar 2008 | - | $1.10 M(-35.7%) | $4.60 M(+7.1%) |
| Dec 2007 | $4.23 M | $1.71 M(+109.5%) | $4.29 M(+25.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | $815.00 K(-16.8%) | $3.42 M(+3.0%) |
| Jun 2007 | - | $979.40 K(+23.6%) | $3.32 M(-0.8%) |
| Mar 2007 | - | $792.10 K(-5.0%) | $3.35 M(+29.4%) |
| Dec 2006 | $3.56 M(+36.8%) | $833.60 K(+16.7%) | $2.58 M(-1.0%) |
| Sep 2006 | - | $714.50 K(-28.9%) | $2.61 M(+9.4%) |
| Jun 2006 | - | $1.00 M(+3050.2%) | $2.39 M(+18.9%) |
| Mar 2006 | - | $31.90 K(-96.3%) | $2.01 M(-22.9%) |
| Dec 2005 | $2.60 M(-38.3%) | $860.40 K(+75.4%) | $2.60 M(-19.5%) |
| Sep 2005 | - | $490.50 K(-21.5%) | $3.23 M(-3.0%) |
| Jun 2005 | - | $625.00 K(-0.5%) | $3.34 M(-14.0%) |
| Mar 2005 | - | $627.90 K(-57.9%) | $3.88 M(+2.5%) |
| Dec 2004 | $4.21 M(+99.4%) | $1.49 M(+151.7%) | $3.78 M(+35.5%) |
| Sep 2004 | - | $592.10 K(-49.2%) | $2.79 M(-4.3%) |
| Jun 2004 | - | $1.17 M(+118.8%) | $2.92 M(+26.2%) |
| Mar 2004 | - | $532.80 K(+6.7%) | $2.31 M(+8.8%) |
| Dec 2003 | $2.11 M(+57.8%) | $499.20 K(-30.5%) | $2.12 M(+8.7%) |
| Sep 2003 | - | $718.00 K(+28.2%) | $1.95 M(+28.5%) |
| Jun 2003 | - | $560.10 K(+62.1%) | $1.52 M(+12.8%) |
| Mar 2003 | - | $345.60 K(+5.0%) | $1.35 M(+3.0%) |
| Dec 2002 | $1.34 M(+33.3%) | $329.10 K(+15.5%) | $1.31 M(+33.6%) |
| Sep 2002 | - | $284.90 K(-26.4%) | $979.00 K(+41.0%) |
| Jun 2002 | - | $387.20 K(+26.2%) | $694.10 K(+126.2%) |
| Mar 2002 | - | $306.90 K(-1.4%) | $306.90 K(-56.6%) |
| Dec 2001 | $1.00 M(+40.6%) | - | - |
| Dec 2000 | $714.30 K(+1092.5%) | $311.30 K(+71.7%) | $707.80 K(+78.5%) |
| Sep 2000 | - | $181.30 K(+10.2%) | $396.50 K(+84.2%) |
| Jun 2000 | - | $164.50 K(+224.5%) | $215.20 K(+324.5%) |
| Mar 2000 | - | $50.70 K | $50.70 K |
| Dec 1999 | $59.90 K | - | - |
FAQ
- What is Oncolytics Biotech annual SGA?
- What is the all time high annual SGA for Oncolytics Biotech?
- What is Oncolytics Biotech annual SGA year-on-year change?
- What is Oncolytics Biotech quarterly SGA?
- What is the all time high quarterly SGA for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly SGA year-on-year change?
- What is Oncolytics Biotech TTM SGA?
- What is the all time high TTM SGA for Oncolytics Biotech?
- What is Oncolytics Biotech TTM SGA year-on-year change?
What is Oncolytics Biotech annual SGA?
The current annual SGA of ONCY is $11.61 M
What is the all time high annual SGA for Oncolytics Biotech?
Oncolytics Biotech all-time high annual SGA is $11.61 M
What is Oncolytics Biotech annual SGA year-on-year change?
Over the past year, ONCY annual SGA has changed by +$3.08 M (+36.10%)
What is Oncolytics Biotech quarterly SGA?
The current quarterly SGA of ONCY is $2.28 M
What is the all time high quarterly SGA for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly SGA is $3.90 M
What is Oncolytics Biotech quarterly SGA year-on-year change?
Over the past year, ONCY quarterly SGA has changed by -$1.63 M (-41.69%)
What is Oncolytics Biotech TTM SGA?
The current TTM SGA of ONCY is -$1.35 B
What is the all time high TTM SGA for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM SGA is -$581.20 K
What is Oncolytics Biotech TTM SGA year-on-year change?
Over the past year, ONCY TTM SGA has changed by -$1.37 B (-11922.31%)